CoChat
Sign Up
Cited by 115Bipolar Disorder and TreatmentTreatment of Major DepressionSchizophrenia research and treatment

The DOI matches its Crossref record; 88 of the 90 references it cites were found in a registry or an index.

Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats

Varela, Roger B., Valvassori, Samira S., Lopes-Borges, Jéssica, Mariot, Edemilson, Dal-Pont, Gustavo C., Amboni, Rafaela T., Bianchini, Guilherme, Quevedo, João·2015·Journal of Psychiatric Research
DOI 10.1016/j.jpsychires.2014.11.003
Open this paper in CoChat — free account

Abstract

Bipolar Disorder (BD) is one of the most severe psychiatric disorders. Despite adequate treatment, patients continue to have recurrent mood episodes, residual symptoms, and functional impairment. Some preclinical studies have shown that histone deacetylase inhibitors may act on manic-like behaviors. Neurotrophins have been considered important mediators in the pathophysiology of BD. The present study aims to investigate the effects of lithium (Li), valproate (VPA), and sodium butyrate (SB), an HDAC inhibitor, on BDNF, NGF and GDNF in the brain of rats subjected to an animal model of mania induced by ouabain. Wistar rats received a single ICV injection of ouabain or artificial cerebrospinal fluid. From the day following ICV injection, the rats were treated for 6 days with intraperitoneal injections of saline, Li, VPA or SB twice a day. In the 7th day after ouabain injection, locomotor activity was measured using the open-field test. The BDNF, NGF and GDNF levels were measured in the hippocampus and frontal cortex by sandwich-ELISA. Li, VPA or SB treatments reversed ouabain-related manic-like behavior. Ouabain decreased BDNF, NGF and GDNF levels in hippocampus and frontal cortex of rats. The treatment with Li, VPA or SB reversed these impairment induced by ouabain. In addition, Li, VPA and SB per se increased NGF and GDNF levels in hippocampus of rats. Our data support the notion that neurotrophic factors play a role in BD and in the mechanisms of the action of Li, VPA and SB.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jpsychires.2014.11.003

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 90 references

Cited by

Sorted by citations

See all 115

Related

Metadata

Authors
Varela, R. B., Valvassori, S. S., Lopes-Borges, J., Mariot, E., Dal-Pont, G. C., Amboni, R. T., Bianchini, G., & Quevedo, J.
Affiliations
Universidade do Extremo Sul Catarinense (BR)
ORCID
Venue
Journal of Psychiatric Research
Publisher
Elsevier BV
Published
2015-02
Volume
61
Pages
114-121
ISSN
0022-3956 (ISSN-L)
DOI
10.1016/j.jpsychires.2014.11.003
OpenAlex
W2068078801
Cited by
115
References
90
Citations by year
2026: 7 · 2025: 16 · 2024: 12 · 2023: 12 · 2022: 12 · 2021: 13 · 2020: 9 · 2019: 9 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 3
FWCI
4.33
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Psychiatric Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Universidade do Extremo Sul Catarinense
  • Instituto Mente e Cérebro - Neurociência
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
sodium butyrate, histone deacetylase inhibitors, bipolar disorder, mania, ouabain, hyperlocomotion, lithium, valproic acid, brain-derived neurotrophic factor, nerve growth factor, glial cell line-derived neurotrophic factor, neurotrophic factors, hippocampus, frontal cortex, mood stabilizers
MeSH terms
Affect, Animals, Bipolar Disorder, Disease Models, Animal, Hippocampus, Histamine Antagonists, Locomotion, Male, Motor Activity, Ouabain, Valproic Acid, Treatment Outcome, Rats, Wistar, Prefrontal Cortex, Lithium Compounds, Antimanic Agents, Brain-Derived Neurotrophic Factor, Butyric Acid, Nerve Growth Factor, Glial Cell Line-Derived Neurotrophic Factor, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review